See also this year's filing and all EDGAR filings for this company.
PDF Report 0000891293_2017_CTI_BIOPHARMA_CORP.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0000891293, CTI BIOPHARMA CORP
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 55,824,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 3,023,000 |
| 3 | remainder_Assets | 4,996,000 |
| 4 | LiabilitiesCurrent | 40,646,000 |
| 5 | LiabilitiesNoncurrent | 14,926,000 |
| 6 | remainder_Liabilities | 514,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 45,306,000 |
| 9 | ResearchAndDevelopmentExpense | 64,961,000 |
| 10 | remainder_Expenses | -3,700,000 |
| 11 | remainder_Revenues | 57,405,000 |
| 12 | remainder_NetIncome | -3,791,000 |
| 13 | remainder_ComprehensiveNetIncome | 1,241,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 63,843,000 |
| 1 | Liabilities | 56,086,000 |
| 2 | Expenses | 106,567,000 |
| 3 | Revenues | 57,405,000 |
| 4 | StockholdersEquity | 7,757,000 |
| 5 | NetIncome | -52,953,000 |
| 6 | ComprehensiveNetIncome | -52,332,500 |
| 7 | BaseVar | 144,466,500 |
| 8 | EconomicCapitalRatio | -0.650 |
Edgar->Model Mapping
Feature Distribution
